HCW Biologics Inc. at its 2023 Annual Meeting of Stockholders approved the election of Rick S. Greene as Class II director to serve for a three-year term expiring at the 2026 Annual Meeting of Stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal.